Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
BMC Oral Health ; 16: 17, 2016 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-26868504

RESUMEN

BACKGROUND: Recurrent Aphthous stomatitis (RAS) is a prevalent ulcerative and painful disorder of the oral cavity with unknown etiology and for which no efficient treatment is currently available. The present study aimed to evaluate the safety and the efficacy of AphtoFix®, a new mouth ulcer cream that was developed to help treat RAS. Prior to launching the product on the market, two initial safety assessment studies were performed. SUBJECTS AND METHODS: In a first study, the in vitro biocompatibility of AphtoFix® was evaluated on reconstructed human gingival tissue models according to ISO guidelines 10993. In a second study, the tolerability of AphtoFix® was evaluated in 20 subjects during a 4-weeks daily application in the mouth. The third study investigated both the safety and efficacy of AphtoFix® treatment on 19 patients suffering from RAS. This study was done in compliance with the Helsinki Declaration. RESULTS: The results of in vitro biocompatibility study showed that AphtoFix® mouth ulcer cream did not induce any detectable cytotoxicity and irritation. These observations were confirmed in the 4 weeks tolerability study where no undesired of adverse reactions were noticed. The results of the post-market clinical efficacy study demonstrated a clear reduction in ulcer size from baseline after 3 days treatment (p < 0.05). Pain intensity reduction was also observed in all subjects. CONCLUSION: The application of AphtoFix® did not induce any undesired skin or mucosa reactions. These initial findings demonstrate that AphtoFix® is safe and efficient in reducing ulcer size and decreasing the pain intensity induced by ulcers. TRIAL REGISTRATION: Clinical trial Registry India Nr. CTRI201408004918 , Date of registration: 22/08/2014.


Asunto(s)
Pomadas/uso terapéutico , Úlceras Bucales/tratamiento farmacológico , Estomatitis Aftosa/tratamiento farmacológico , Adulto , Células Cultivadas , Femenino , Encía/citología , Humanos , India , Queratinocitos/efectos de los fármacos , Masculino , Ensayo de Materiales , Recurrencia
2.
J Toxicol Environ Health A ; 75(13-15): 934-46, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22788378

RESUMEN

Of all workers exposed globally to synthetic sources of radiation, medical personnel represent the largest group, but receive relatively low doses. Accidental or therapeutic acute radiation exposure of humans was observed to induce various forms of cytogenetic damage, including the possibility of increasing the incidence of micronuclei (MN) and chromosomal aberrations (CA). The aim of this study was to assess occupationally induced chromosomal damage in a large population of hospital workers exposed to low doses of ionizing radiation (IR). The cytokinesis-block MN and comet assays were used to examine peripheral blood lymphocytes (PBL) of 31 exposed workers to IR and 33 control subjects corresponding in gender, age, and smoking. Glutathione S-transferases (GSTM1, GSTT1, and GSTP1) are postulated to be involved in the detoxification of endogenous and exogenous genotoxicants. The association between these biomarkers and polymorphic genes of xenobiotic metabolizing enzymes was thus also assessed. MN frequency was significantly higher in the exposed subjects compared controls. Comet assay results showed a significant increase of tail length in workers exposed to IR. Data obtained suggest that GSTM1, GSTT1, and GSTP1 polymorphism do not modify significantly the genotoxic potential of IR. Therefore, the exposed medical personnel need to carefully apply radiation protection procedures and minimize, as low as possible, IR exposure to avoid possible genotoxic effects.


Asunto(s)
Cromosomas Humanos/efectos de la radiación , Daño del ADN , Glutatión Transferasa/genética , Personal de Hospital , Polimorfismo Genético , Traumatismos por Radiación/genética , Servicio de Radiología en Hospital , Accidentes de Trabajo , Adulto , Femenino , Estudios de Asociación Genética , Gutatión-S-Transferasa pi/genética , Gutatión-S-Transferasa pi/metabolismo , Glutatión Transferasa/metabolismo , Hospitales Urbanos , Humanos , Incidencia , Linfocitos/metabolismo , Linfocitos/efectos de la radiación , Masculino , Micronúcleos con Defecto Cromosómico , Persona de Mediana Edad , Traumatismos por Radiación/epidemiología , Traumatismos por Radiación/metabolismo , Liberación de Radiactividad Peligrosa , Túnez/epidemiología , Recursos Humanos
3.
Environ Sci Pollut Res Int ; 23(11): 11163-11170, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26916269

RESUMEN

In general, people may come in contact with mixtures of insecticides through domestic use, consumption of contaminated food or drinks, and/or living close to treated areas. We analyzed the toxic effects of diazinon on histological structure of liver and hematological parameters in male rats. DNA-damaging potential of diazinon was also investigated using the comet assay in blood cells and the micronucleus test in bone marrow. Two groups of six male rats orally received different amounts of diazinon: 1/50 and 1/25 LD 50 for 4 weeks (5 day/week). The present study showed that diazinon caused hypertrophy of sinusoids, central vein, and portal triad, in addition to the formation of oedema, vacuoles, hemorrhage, necrosis, and lymphoid infiltration in rats' liver. A significant decrease in red blood cells, hemoglobin, hematocrite levels, and platelet counts was observed in the treated groups. However, the white blood cell count increased. Micronucleus test results revealed aneugenic effects of diazinon. Furthermore, we noticed an increase in comet tail length in treated groups. So, the comet assay confirmed the genotoxic potential of diazinon in vivo. On the assumption that all alterations observed in rats could be observed in human, it is necessary to raise the awareness about the health risk posed by this insecticide.


Asunto(s)
Células de la Médula Ósea/efectos de los fármacos , Daño del ADN , Diazinón/toxicidad , Insecticidas/toxicidad , Hígado/efectos de los fármacos , Animales , Células Sanguíneas/efectos de los fármacos , Ensayo Cometa , Contaminantes Ambientales/toxicidad , Masculino , Pruebas de Micronúcleos , Ratas Wistar , Pruebas de Toxicidad Subaguda
4.
Environ Sci Pollut Res Int ; 23(5): 4859-67, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26545888

RESUMEN

This study aims to investigate the effects of chlorpyrifos's sub-acute exposure on male rats. Two groups with six animals each were orally treated, respectively, with 3.1 mg/kg b w and 6.2 mg/kg b w of chlorpyrifos during 4 weeks. The genotoxic effect of chlopyrifos was investigated using the comet assay and the micronucleus test. Some hematological and liver's histopathological changes were also evaluated. Results revealed that chlorpyrifos induced histopathological alterations in liver parenchyma. The lymphoid infiltration observed in liver sections and the increase in white blood cells parameter are signs of inflammation. A significant increase in the platelet' count and in polychromatic erythrocytes/normochromatic erythrocytes (PCE/NCE) ratio was observed in chlorpyrifos-treated groups which could be due to the stimulatory effect of chlorpyrifos on cell formation in the bone marrow at lower doses. In addition, the increase of bone marrow micronucleus percentage and the comet tail length revealed a genotoxic potential of chlorpyrifos in vivo.


Asunto(s)
Cloropirifos/toxicidad , Daño del ADN , Contaminantes Ambientales/toxicidad , Hígado/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Médula Ósea/efectos de los fármacos , Médula Ósea/patología , Ensayo Cometa , Relación Dosis-Respuesta a Droga , Eritrocitos/efectos de los fármacos , Eritrocitos/patología , Leucocitos/efectos de los fármacos , Leucocitos/patología , Hígado/patología , Masculino , Pruebas de Micronúcleos , Tamaño de los Órganos/efectos de los fármacos , Recuento de Plaquetas , Ratas , Ratas Wistar
5.
Genet Test Mol Biomarkers ; 17(9): 650-5, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23216272

RESUMEN

Epidemiological studies suggest that cytogenetic biomarkers, such as micronuclei (MN) in peripheral blood lymphocytes may predict cancer risk because they indicate genomic instability. The objective of the present study was to evaluate the frequencies of MN and chromosome aberrations (CA) in peripheral blood lymphocytes of hospital workers exposed to ionizing radiation and healthy subjects. The study was conducted using peripheral blood lymphocytes from 30 workers from the radiology department and 30 from the cardiology department. This study included 27 healthy age- and sex-matched individuals as the control group. The assessment of chromosomal damage was carried out by the use of CA and micronucleus assays in peripheral lymphocytes. Our results show that CA and micronucleus frequencies were significantly higher among the exposed groups when compared to controls. Our finding of significant increase of CA and MN frequencies in peripheral lymphocytes in exposed workers indicates a potential cytogenetic hazard due to this exposure. The enhanced chromosomal damage of subjects exposed to genotoxic agents emphasizes the need to develop safety programs.


Asunto(s)
Exoma , Genoma Humano , Participación del Paciente , Humanos
6.
Artículo en Inglés | MEDLINE | ID: mdl-19832697

RESUMEN

Occupational healthcare may expose to various allergens and irritants. Thus, the allergic manifestations in nursing staff are frequent and their prevalence is increasing all over the world. In fact, many new substances continuously appear in the medical practices. These allergic manifestations include a wide spectrum of clinical symptoms such as ocular, nasal and especially bronchial symptoms, which can be isolated or associated. These diseases can be a source of many problems related to the occupational aptitude. All these conditions justify prevention procedure strengthening, which mainly consist in substituting the sensitizing agents, and applying collective and individual prevention measures. This article also refers to some patents on the treatment of allergy.


Asunto(s)
Alérgenos/efectos adversos , Personal de Salud , Hipersensibilidad/fisiopatología , Enfermedades Profesionales/fisiopatología , Exposición Profesional/efectos adversos , Desinfectantes , Formaldehído , Guías como Asunto , Humanos , Hipersensibilidad/diagnóstico , Hipersensibilidad/prevención & control , Látex , Enfermedades Profesionales/diagnóstico , Enfermedades Profesionales/prevención & control , Patentes como Asunto , Compuestos de Amonio Cuaternario
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA